Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421832

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421832

Periodic Fever Syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication ; By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032

PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global periodic fever syndrome market size is expected to reach USD 881.95 million by 2032, according to a new study by Polaris Market Research. The report "Periodic fever syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication (Hyper-immunoglobulinemia D syndrome, Familial Mediterranean Fever, TNF Receptor Associated periodic syndrome, Cryopyrin Associated periodic syndrome, Others); By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rise of the sector is being aided by a rise in government programs focused on raising public knowledge of uncommon disorders. Increased research activity and quick technical breakthroughs are resulting in the creation of new medications, enhanced diagnostic capabilities, and treatments, all of which contribute significantly to market growth. The sector is likely to benefit from new medication approvals to treat the condition.

FMF is the most prevalent monogenic autoinflammatory illness in the world and in Canada, with repeated, self-limited bouts of fever and inflammation involving serous and synovial membranes. It is inherited in an autosomal recessive manner, and its incidence is highest among groups of Middle Eastern and Mediterranean ancestry, with varying prevalence in other ethnicities.

Cryopyrin-associated periodic syndrome (CAPS) is a series of autoinflammatory illnesses that are connected. Mutations in the CIASl gene, which encodes cryopyrin, induce the enhanced activity of interleukin I and other cytokines, which activate their target cells via an intracellular receptor known as the Toll-like receptor or nucleotide oligomerization domain protein ligation.

Ilaris is the first and only FDA-approved biologic therapy for TRAPS, Hyper immunoglobulin D Syndrome, & Familial Mediterranean Fever. All three disorders are part of a rare category of auto-inflammatory diseases known as Periodic Fever Syndromes. FMF is the most frequent condition, affecting primarily those of Eastern Mediterranean heritage. It affects 1 in 250 to 1 in 1,000 people in various populations, with a majority of them being children.

Commonly used medications, such as hydroxychloroquine, have seen a huge increase in demand for COVID-19 control. Because of the need for vaccinations and treatment medications for COVID-19, the biopharma industry is likely to increase significantly in the future. This, in turn, is projected to have a major influence on the market for periodic fever syndrome. Recently, Canakinumab has been licensed for the treatment of individuals with periodic fever syndrome, cryopyrin-associated periodic syndrome, periodic fever syndrome, and systemic juvenile systemic arthritis which likely boosts the growth of periodic fever syndrome business.

Periodic Fever Syndrome Market Report Highlights

Oral anti-inflammatory medicines such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs), among others, are expected to hold a significant market share over the projection period as these are used to treat periodic fever syndrome.

North America is a market leader in the worldwide periodic fever syndrome sector due to the expanding penetration of the region's key companies and the increased emphasis on patient care and monitoring.

The global players include: Merck & Co Inc, Simvastatin, Swedish Orphan Biovitrum AB, and Novartis AG.

Polaris Market Research has segmented the periodic fever syndrome market report based on indication, treatment, end-use and region:

Periodic Fever Syndrome, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Hyperimmunoglobulinemia D syndrome
  • Familial Mediterranean Fever (FMF)
  • TNF Receptor Associated Periodic Syndrome (TRAPS)
  • Cryopyrin Associated Periodic Syndrome
  • Others

Periodic Fever Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral anti-inflammatory drugs
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Anti-TNF therapy
  • Statins
  • Others

Periodic fever syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Retail Pharmacy

Periodic fever syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Show more
Product Code: PM4152

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Periodic Fever Syndrome Market Insights

  • 4.1. Periodic Fever Syndrome Market - Treatment Snapshot
  • 4.2. Periodic Fever Syndrome Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Genetic Research
      • 4.2.1.2. Growing awareness among healthcare professionals, patients
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Patient Pool
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Periodic Fever Syndrome Market Treatment Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Periodic Fever Syndrome Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • 5.3. HyperimmunoGlobulinemia D syndrome (HIDS)
    • 5.3.1. Global Periodic Fever Syndrome Market, by HyperimmunoGlobulinemia D syndrome (HIDS), by Region, 2019-2032 (USD Million)
  • 5.4. Familial Mediterranean Fever (FMF)
    • 5.4.1. Global Periodic Fever Syndrome Market, by Familial Mediterranean Fever (FMF), by Region, 2019-2032 (USD Million)
  • 5.5. TNF Receptor-Associated Periodic Syndrome (TRAPS)
    • 5.5.1. Global Periodic Fever Syndrome Market, by TNF Receptor-Associated Periodic Syndrome (TRAPS), by Region, 2019-2032 (USD Million)
  • 5.6. Cryopyrin-Associated Periodic Syndrome
    • 5.6.1. Global Periodic Fever Syndrome Market, by Cryopyrin-Associated Periodic Syndrome, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Periodic Fever Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Periodic Fever Syndrome Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Periodic Fever Syndrome Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Periodic Fever Syndrome Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)

7. Global Periodic Fever Syndrome Market, by Treatment

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • 7.3. Oral anti-inflammatory drugs
    • 7.3.1. Global Periodic Fever Syndrome Market, by Oral anti-inflammatory drugs, By Region, 2019-2032 (USD Million)
  • 7.4. Non-steroidal anti-inflammatory drugs (NSAIDs)
    • 7.4.1. Global Periodic Fever Syndrome Market, by Non-steroidal anti-inflammatory drugs (NSAIDs), By Region, 2019-2032 (USD Million)
  • 7.5. Anti-TNF therapy
    • 7.5.1. Global Periodic Fever Syndrome Market, by Anti-TNF therapy, By Region, 2019-2032 (USD Million)
  • 7.6. Statins
    • 7.6.1. Global Periodic Fever Syndrome Market, by Statins, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Periodic Fever Syndrome Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Periodic Fever Syndrome Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Periodic Fever Syndrome Market - North America
    • 8.3.1. North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.3.2. North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.3. North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.4. Periodic Fever Syndrome Market - U.S.
      • 8.3.4.1. U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.5. Periodic Fever Syndrome Market - Canada
      • 8.3.5.1. Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.4. Periodic Fever Syndrome Market - Europe
    • 8.4.1. Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.3. Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.4. Periodic Fever Syndrome Market - UK
      • 8.4.4.1. UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.5. Periodic Fever Syndrome Market - France
      • 8.4.5.1. France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.5.3. France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.6. Periodic Fever Syndrome Market - Germany
      • 8.4.6.1. Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.7. Periodic Fever Syndrome Market - Italy
      • 8.4.7.1. Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.8. Periodic Fever Syndrome Market - Spain
      • 8.4.8.1. Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.9. Periodic Fever Syndrome Market - Netherlands
      • 8.4.9.1. Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.10. Periodic Fever Syndrome Market - Russia
      • 8.4.10.1. Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.5. Periodic Fever Syndrome Market - Asia Pacific
    • 8.5.1. Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.4. Periodic Fever Syndrome Market - China
      • 8.5.4.1. China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.4.3. China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.5. Periodic Fever Syndrome Market - India
      • 8.5.5.1. India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.5.3. India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.6. Periodic Fever Syndrome Market - Malaysia
      • 8.5.6.1. Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.7. Periodic Fever Syndrome Market - Japan
      • 8.5.7.1. Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.8. Periodic Fever Syndrome Market - Indonesia
      • 8.5.8.1. Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.9. Periodic Fever Syndrome Market - South Korea
      • 8.5.9.1. South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.6. Periodic Fever Syndrome Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.4. Periodic Fever Syndrome Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.5. Periodic Fever Syndrome Market - UAE
      • 8.6.5.1. UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.6. Periodic Fever Syndrome Market - Israel
      • 8.6.6.1. Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.7. Periodic Fever Syndrome Market - South Africa
      • 8.6.7.1. South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.7. Periodic Fever Syndrome Market - Latin America
    • 8.7.1. Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.4. Periodic Fever Syndrome Market - Mexico
      • 8.7.4.1. Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.5. Periodic Fever Syndrome Market - Brazil
      • 8.7.5.1. Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.6. Periodic Fever Syndrome Market - Argentina
      • 8.7.6.1. Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Merck & Co Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Novartis AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Simvastatin
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Swedish Orphan Biovitrum AB
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
Show more
Product Code: PM4152

List of Tables

  • Table 1 Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 2 Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 3 Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 4 Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 6 North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 7 North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 8 U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 10 U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 11 Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 12 Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 13 Canada: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 14 Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 15 Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 16 Europe: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 17 UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 18 UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 19 UK: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 20 France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 21 France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 22 France: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 23 Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 25 Germany: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 26 Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 27 Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 28 Italy: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 29 Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 30 Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 31 Spain: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 32 Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 33 Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 34 Netherlands: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 35 Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 36 Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 37 Russia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 41 China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 42 China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 43 China: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 44 India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 45 India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 46 India: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 47 Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 48 Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 49 Malaysia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 50 Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 51 Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 52 Japan: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 53 Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 54 Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 55 Indonesia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 56 South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 57 South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 58 South Korea: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 65 UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 66 UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 67 UAE: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 68 Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 69 Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 70 Israel: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 71 South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 72 South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 73 South Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 74 Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 75 Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 76 Latin America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 77 Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 78 Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 79 Mexico: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 80 Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 81 Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 82 Brazil: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 83 Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 84 Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 85 Argentina: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Periodic Fever Syndrome Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End-Use
  • Figure 7. Global Periodic Fever Syndrome Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 8. Market by Indication
  • Figure 9. Global Periodic Fever Syndrome Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 10. Market by Treatment
  • Figure 11. Global Periodic Fever Syndrome Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 12. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Periodic Fever Syndrome Market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!